Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Front Oncol ; 14: 1394111, 2024.
Article in English | MEDLINE | ID: mdl-38873258

ABSTRACT

Purpose: We tried to establish the normal tissue complication probability (NTCP) model of temporal lobe injury of recurrent nasopharyngeal carcinoma (NPC) patients after two courses of intensity modulated radiotherapy (IMRT) to provide more reliable dose-volume data reference to set the temporal lobe tolerance dose for recurrent NPC patients in the future. Methods and materials: Recurrent NPC patients were randomly divided into training data set and validation data set in a ratio of 2:1, All the temporal lobes (TLs) were re-contoured as R/L structures and named separately in the MIM system. The dose distribution of the initial IMRT plan was deformed into the second course planning CT via MIM software to get the deformed dose. Equivalent dose of TLs in 2Gy fractions was calculated via linear quadratic model, using an α/ß=3 for temporal lobes. NTCP model that correlated the irradiated volume of the temporal lobe and? the clinical variables were evaluated in a multivariate prediction model using AUC analysis. Results: From Jan. 2010 to Dec. 2020, 78 patients were enrolled into our study. Among which 26 (33.3%) developed TLI. The most important factors affecting TLI was the sum-dose d1.5cc of TL, while the possible clinical factors did not reach statistically significant differences in multivariate analysis. According to NTCP model, the TD5 and TD50 EQD2 dose of sum-dose d1.5cc were 65.26Gy (46.72-80.69Gy) and 125.25Gy (89.51-152.18Gy), respectively. For the accumulated EQD2 dose, the area under ROC shadow was 0.8702 (0.7577-0.9828) in model validation, p<0.001. Conclusion: In this study, a NTCP model of temporal lobe injury after a second course of IMRT for recurrent nasopharyngeal carcinoma was established. TD5 and TD50 doses of temporal lobe injury after re-RT were obtained according to the model, and the model was verified by validation set data.

2.
Radiat Oncol ; 17(1): 166, 2022 Oct 13.
Article in English | MEDLINE | ID: mdl-36229849

ABSTRACT

BACKGROUND: Script-based planning and knowledge-based planning are two kinds of automatic planning solutions. Hybrid automatic planning may integrate the advantages of both solutions and provide a more robust automatic planning solution in the clinic. In this study, we evaluated and compared a commercially available hybrid planning solution with manual planning and script-based planning. METHODS: In total, 51 rectal cancer patients in our institution were enrolled in this study. Each patient generated 7 plans: one clinically accepted manual plan ([Formula: see text]), three script-based plans and three hybrid plans generated with the volumetric-modulated arc therapy technique and 3 different clinical goal settings: easy, moderate and hard ([Formula: see text], [Formula: see text], [Formula: see text], [Formula: see text], [Formula: see text] and [Formula: see text]). Planning goals included planning target volume (PTV) Dmax, bladder Dmean and femur head Dmean. The PTV prescription was the same (50.00 Gy) for the 3 goal settings. The hard setting required a lower PTV Dmax and stricter organ at risk (OAR) dose, while the easy setting was the opposite. Plans were compared using dose metrics and plan quality metric (PQM) scores, including bladder D15 and D50, left and right femur head D25 and D40, PTV D2, D98, CI (conformity index) and HI (homogeneity index). RESULTS: Compared to manual planning, hybrid planning with all settings significantly reduced the OAR dose (p < 0.05, paired t-test or Wilcoxon signed rank test) for all dose-volume indices, except D25 of the left femur head. For script-based planning, [Formula: see text] significantly increased the OAR dose for the femur head and D2 and the PTV homogeneity index (p < 0.05, paired t-test or Wilcoxon signed rank test). Meanwhile, the maximum dose of the PTV was largely increased with hard script-based planning (D2 = 56.06 ± 7.57 Gy). For all three settings, the comparison of PQM between hybrid planning and script-based planning showed significant differences, except for D25 of the left femur head and PTV D2. The total PQM showed that hybrid planning could provide a better and more robust plan quality than script-based planning. CONCLUSIONS: The hybrid planning solution was manual-planning comparable for rectal cancer. Hybrid planning can provide a better and more robust plan quality than script-based planning.


Subject(s)
Radiotherapy, Intensity-Modulated , Rectal Neoplasms , Humans , Knowledge Bases , Organs at Risk , Radiotherapy Dosage , Radiotherapy Planning, Computer-Assisted/methods , Radiotherapy, Intensity-Modulated/methods , Rectal Neoplasms/radiotherapy
3.
Phys Med Biol ; 67(22)2022 Nov 04.
Article in English | MEDLINE | ID: mdl-36220015

ABSTRACT

Objective.Adaptive radiation therapy (ART) could protect organs at risk (OARs) while maintain high dose coverage to targets. However, there is still a lack of efficient online patient quality assurance (QA) methods, which is an obstacle to large-scale adoption of ART. We aim to develop a clinically relevant online patient QA solution for ART using daily CT scans and EPID-basedin vivodosimetry.Approach.Ten patients with rectal cancer at our center were included. Patients' daily CT scans and portal images were collected to generate reconstructed 3D dose distributions. Contours of targets and OARs were recontoured on these daily CT scans by a clinician or an auto-segmentation algorithm, then dose-volume indices were calculated, and the percent deviation of these indices to their original plans were determined. This deviation was regarded as the metric for clinically relevant patient QA. The tolerance level was obtained using a 95% confidence interval of the QA metric distribution. These deviations could be further divided into anatomically relevant or delivery relevant indicators for error source analysis. Finally, our QA solution was validated on an additional six clinical patients.Main results.In rectal cancer, the 95% confidence intervals of the QA metric for PTV ΔD95(%) were [-3.11%, 2.35%], and for PTV ΔD2(%) were [-0.78%, 3.23%]. In validation, 68% for PTV ΔD95(%), and 79% for PTV ΔD2(%) of the 28 fractions are within tolerances of the QA metrics. one patient's dosimetric impact of anatomical variations during treatment were observed through the source of error analysis.Significance.The online patient QA solution using daily CT scans and EPID-basedin vivodosimetry is clinically feasible. Source of error analysis has the potential for distinguishing sources of error and guiding ART for future treatments.


Subject(s)
Radiotherapy, Intensity-Modulated , Rectal Neoplasms , Humans , Radiotherapy Planning, Computer-Assisted/methods , Radiotherapy, Intensity-Modulated/methods , Feasibility Studies , Tomography, X-Ray Computed , Rectal Neoplasms/diagnostic imaging , Rectal Neoplasms/radiotherapy , Radiotherapy Dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...